Balanced news tone
News Sentiment
LNAI sentiment intelligence
Lunai Bioworks Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
52 relevant articles
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+56.8% over one week, +67.3% over four weeks, trend inactive, and below fair value.
$Lunai Bioworks (LNAI.US)$
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
83/100 classification
One-week reaction
56.8%
Price confirming higher
Trend fit
Trend inactive
67.3% over four weeks
Fair value
-95.9%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
15
Neutral
30
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Associated Press
Direct company coverage
Lunai Bioworks: Fiscal Q3 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 21:04
- Source
- Associated Press
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Investing.com
Direct company coverage
Lunai Bioworks shareholders approve reverse stock split and meeting adjournment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Investing.com
Stock Titan
Direct company coverage
Lunai Bioworks (NASDAQ: LNAI) wins shareholder approval for reverse stock split
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 13 May 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Lunai Bioworks (LNAI) warns of Nasdaq delisting risk after MVLS shortfall
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 12:30
- Source
- GlobeNewswire
PR Newswire
Direct company coverage
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 13:35
- Source
- PR Newswire
Stock Titan
Direct company coverage
Lunai Bioworks (NASDAQ: LNAI) issues $20M preferred to acquire CNS patents, aid Nasdaq equity test
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Lunai Bioworks (NASDAQ: LNAI) files proxy supplement; Reverse Split on ballot
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Lunai Bioworks (NASDAQ: LNAI) moves special vote to May 8
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
PR Newswire
Direct company coverage
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 13:10
- Source
- PR Newswire
Stock Titan
Direct company coverage
Lunai Bioworks (LNAI) seeks approval for wide-range reverse stock split to support Nasdaq listing
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 13 Apr 2026 07:00
- Source
- Stock Titan
Market source
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Nasdaq moves to delist Lunai Bioworks (LNAI) after 30 days under $1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Feb 2026 08:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
AI firm Lunai Bioworks targets 30M with poorly treated Alcohol Use Disorder
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jan 2026 08:00
- Source
- Stock Titan
simplywall.st
Industry context
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Dec 2025 08:00
- Source
- simplywall.st
Stocktwits
Direct company coverage
LNAI: Lunai Bioworks Inc. Latest Stock Price, Analysis, News and Trading Ideas
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Oct 2025 17:05
- Source
- Stocktwits
MarketBeat
Direct company coverage
Lunai Bioworks (RENB) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Aug 2023 13:10
- Source
- MarketBeat